Literature DB >> 16785461

Evidence and advocacy: are all things considered?

Jeffrey A Johnson1, Alun L Edwards.   

Abstract

Mesh：

Year:  2006        PMID： 16785461      PMCID： PMC1475909          DOI： 10.1503/cmaj.060231

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  What is the quality of drug therapy clinical practice guidelines in Canada?

Authors:  I D Graham; S Beardall; A O Carter; J Glennie; P C Hébert; J M Tetroe; F A McAlister; S Visentin; G M Anderson
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

Review 2.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

3.  Economic analyses and clinical practice guidelines: why not a match made in heaven?

Authors:  Scott D Ramsey
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

4.  Group judgments of appropriateness: the effect of panel composition.

Authors:  L L Leape; R E Park; J P Kahan; R H Brook
Journal:  Qual Assur Health Care       Date:  1992-06

5.  Clinical practice guidelines and conflict of interest.

Authors: 
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

6.  On bias and transparency in the development of influential recommendations.

Authors:  Andreas Laupacis
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

7.  The Canadian Diabetes Association guidelines: putting the evidence first.

Authors:  Michael C Howlett; Donna Lillie
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

Review 8.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

Authors:  S Meltzer; L Leiter; D Daneman; H C Gerstein; D Lau; S Ludwig; J F Yale; B Zinman; D Lillie
Journal:  CMAJ       Date:  1998       Impact factor: 8.262
  8 in total
  1 in total

Review 1.  From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy.

Authors:  Marisa E Hilliard; Sean M Oser; Kelly L Close; Nancy F Liu; Korey K Hood; Barbara J Anderson
Journal:  Curr Diab Rep       Date:  2015-09       Impact factor: 4.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.